Fund profile
Tickers
BIB
Fund manager
Total assets
$85.57 mm
Liabilities
$10.80 mm
Net assets
$74.77 mm
Number of holdings
276.00
BIB stock data
Top 200 of 276 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
AMGN AMGEN Inc. | 5.52 mm | 20.46 k shares | 7.38 | Common equity | Long | USA |
VRTX Vertex Pharmaceuticals, Inc. | 5.34 mm | 15.05 k shares | 7.14 | Common equity | Long | USA |
GILD Gilead Sciences, Inc. | 5.25 mm | 68.56 k shares | 7.02 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 5.23 mm | 6.35 k shares | 6.99 | Common equity | Long | USA |
SGEN Seagen Inc. | 2.55 mm | 11.97 k shares | 3.41 | Common equity | Long | USA |
AstraZeneca plc
|
2.40 mm | 37.15 k shares | 3.21 | Common equity | Long | UK |
BIIB Biogen Inc | 2.16 mm | 9.24 k shares | 2.89 | Common equity | Long | USA |
Repurchase Agreement
BNP Paribas Securities Corp.
|
1.98 mm | 1.98 mm principal | 2.65 | Repurchase agreement | Long | USA |
MRNA Moderna Inc | 1.89 mm | 24.27 k shares | 2.52 | Common equity | Long | USA |
ALNY Alnylam Pharmaceuticals Inc | 1.34 mm | 7.97 k shares | 1.79 | Common equity | Long | USA |
BMRN Biomarin Pharmaceutical Inc. - Registered Shares | 1.09 mm | 12.00 k shares | 1.46 | Common equity | Long | USA |
INVESCO GOVERNMENT & AGENCY PORTFOLIO OPEN-END FUND USD | 1.09 mm | 1.09 mm shares | 1.45 | Short-term investment vehicle | Long | USA |
ILMN Illumina Inc | 1.03 mm | 10.10 k shares | 1.38 | Common equity | Long | USA |
Repurchase Agreement
ING Financial Markets LLC
|
859.44 k | 859.44 k principal | 1.15 | Repurchase agreement | Long | USA |
ARGX Argen X SE | 855.26 k | 1.90 k shares | 1.14 | Common equity | Long | Netherlands |
SNY Sanofi | 840.85 k | 17.99 k shares | 1.12 | Common equity | Long | France |
INCY Incyte Corp. | 776.57 k | 14.29 k shares | 1.04 | Common equity | Long | USA |
Royalty Pharma plc, Class A
|
775.04 k | 28.63 k shares | 1.04 | Common equity | Long | UK |
NBIX Neurocrine Biosciences, Inc. | 725.89 k | 6.23 k shares | 0.97 | Common equity | Long | USA |
UTHR United Therapeutics Corp | 718.56 k | 2.99 k shares | 0.96 | Common equity | Long | USA |
VTRS Viatris Inc | 702.29 k | 76.50 k shares | 0.94 | Common equity | Long | USA |
BNTX BioNTech SE | 598.34 k | 5.96 k shares | 0.80 | Common equity | Long | Germany |
MEDP Medpace Holdings Inc | 527.63 k | 1.95 k shares | 0.71 | Common equity | Long | USA |
Repurchase Agreement
BOFA SECURITIES, INC.
|
523.38 k | 523.38 k principal | 0.70 | Repurchase agreement | Long | USA |
BeiGene Ltd.
|
501.56 k | 2.68 k shares | 0.67 | Common equity | Long | Cayman Islands |
SRPT Sarepta Therapeutics Inc | 483.53 k | 5.95 k shares | 0.65 | Common equity | Long | USA |
Jazz Pharmaceuticals plc
|
475.99 k | 4.03 k shares | 0.64 | Common equity | Long | Ireland |
Roivant Sciences Ltd.
|
470.52 k | 49.22 k shares | 0.63 | Common equity | Long | Bermuda |
IMGN Immunogen, Inc. | 465.99 k | 15.88 k shares | 0.62 | Common equity | Long | USA |
KRTX Karuna Therapeutics Inc | 459.29 k | 2.40 k shares | 0.61 | Common equity | Long | USA |
IONS Ionis Pharmaceuticals Inc | 452.21 k | 9.14 k shares | 0.60 | Common equity | Long | USA |
EXEL Exelixis Inc | 442.83 k | 20.30 k shares | 0.59 | Common equity | Long | USA |
APLS Apellis Pharmaceuticals Inc | 404.51 k | 7.51 k shares | 0.54 | Common equity | Long | USA |
Repurchase Agreement
Barclays Capital, Inc.
|
392.93 k | 392.93 k principal | 0.53 | Repurchase agreement | Long | USA |
ITCI Intra-Cellular Therapies Inc | 376.08 k | 6.13 k shares | 0.50 | Common equity | Long | USA |
ASND Ascendis Pharma A/S | 365.57 k | 3.64 k shares | 0.49 | Common equity | Long | Denmark |
IMVT Immunovant Inc | 360.74 k | 9.22 k shares | 0.48 | Common equity | Long | USA |
CRISPR Therapeutics AG
|
337.92 k | 5.06 k shares | 0.45 | Common equity | Long | Switzerland |
ABCZF Abcam plc | 328.10 k | 13.69 k shares | 0.44 | Common equity | Long | UK |
HALO Halozyme Therapeutics Inc. | 324.83 k | 8.41 k shares | 0.43 | Common equity | Long | USA |
PCVX Vaxcyte Inc | 309.84 k | 5.99 k shares | 0.41 | Common equity | Long | USA |
LEGN Legend Biotech Corp | 309.03 k | 5.08 k shares | 0.41 | Common equity | Long | Cayman Islands |
BBIO BridgeBio Pharma Inc | 297.46 k | 10.36 k shares | 0.40 | Common equity | Long | USA |
BPMC Blueprint Medicines Corp | 269.37 k | 3.87 k shares | 0.36 | Common equity | Long | USA |
Alkermes plc
|
256.29 k | 10.62 k shares | 0.34 | Common equity | Long | Ireland |
RVMD Revolution Medicines Inc | 251.36 k | 10.77 k shares | 0.34 | Common equity | Long | USA |
MRTX Mirati Therapeutics Inc | 247.09 k | 4.35 k shares | 0.33 | Common equity | Long | USA |
MDGL Madrigal Pharmaceuticals Inc | 239.49 k | 1.18 k shares | 0.32 | Common equity | Long | USA |
NUVL Nuvalent Inc - Ordinary Shares | 237.29 k | 3.63 k shares | 0.32 | Common equity | Long | USA |
ACAD Acadia Pharmaceuticals Inc | 232.65 k | 10.44 k shares | 0.31 | Common equity | Long | USA |
INSM Insmed Inc | 229.46 k | 9.17 k shares | 0.31 | Common equity | Long | USA |
Repurchase Agreement
Barclays Capital, Inc.
|
220.37 k | 220.37 k principal | 0.29 | Repurchase agreement | Long | USA |
Repurchase Agreement
BNP Paribas Securities Corp.
|
220.37 k | 220.37 k principal | 0.29 | Repurchase agreement | Long | USA |
CYTK Cytokinetics Inc | 204.96 k | 6.12 k shares | 0.27 | Common equity | Long | USA |
RARE Ultragenyx Pharmaceutical Inc. | 203.22 k | 5.23 k shares | 0.27 | Common equity | Long | USA |
AXSM Axsome Therapeutics Inc | 202.96 k | 3.01 k shares | 0.27 | Common equity | Long | USA |
FOLD Amicus Therapeutics Inc | 201.80 k | 18.31 k shares | 0.27 | Common equity | Long | USA |
GH Guardant Health Inc | 188.93 k | 7.51 k shares | 0.25 | Common equity | Long | USA |
KRYS Krystal Biotech Inc | 186.15 k | 1.79 k shares | 0.25 | Common equity | Long | USA |
AMPH Amphastar Pharmaceuticals Inc | 175.44 k | 3.12 k shares | 0.23 | Common equity | Long | USA |
NTLA Intellia Therapeutics Inc | 167.20 k | 5.64 k shares | 0.22 | Common equity | Long | USA |
DNLI Denali Therapeutics Inc | 162.33 k | 8.77 k shares | 0.22 | Common equity | Long | USA |
ACLX Arcellx Inc | 162.06 k | 3.09 k shares | 0.22 | Common equity | Long | USA |
IBRX ImmunityBio Inc | 156.68 k | 42.58 k shares | 0.21 | Common equity | Long | USA |
XENE Xenon Pharmaceuticals Inc | 149.61 k | 4.09 k shares | 0.20 | Common equity | Long | Canada |
ARWR Arrowhead Pharmaceuticals Inc. | 144.92 k | 6.84 k shares | 0.19 | Common equity | Long | USA |
BEAM Beam Therapeutics Inc | 141.83 k | 5.05 k shares | 0.19 | Common equity | Long | USA |
CFRXQ CONTRAFECT Corp | 135.51 k | 15.98 k shares | 0.18 | Common equity | Long | USA |
CBAY Cymabay Therapeutics Inc | 135.06 k | 7.06 k shares | 0.18 | Common equity | Long | USA |
CRNX Crinetics Pharmaceuticals Inc | 134.06 k | 4.22 k shares | 0.18 | Common equity | Long | USA |
RCKT Rocket Pharmaceuticals Inc | 133.94 k | 5.74 k shares | 0.18 | Common equity | Long | USA |
IDYA Ideaya Biosciences Inc | 129.20 k | 4.11 k shares | 0.17 | Common equity | Long | USA |
RYTM Rhythm Pharmaceuticals Inc. | 121.32 k | 3.63 k shares | 0.16 | Common equity | Long | USA |
SWTX SpringWorks Therapeutics Inc | 121.29 k | 3.99 k shares | 0.16 | Common equity | Long | USA |
VCYT Veracyte Inc | 118.78 k | 4.64 k shares | 0.16 | Common equity | Long | USA |
Prothena Corp. plc
|
111.23 k | 3.41 k shares | 0.15 | Common equity | Long | Ireland |
HRMY Harmony Biosciences Holdings Inc | 111.21 k | 3.83 k shares | 0.15 | Common equity | Long | USA |
PTCT PTC Therapeutics Inc | 110.63 k | 4.81 k shares | 0.15 | Common equity | Long | USA |
Immunocore Holdings plc
|
110.31 k | 2.09 k shares | 0.15 | Common equity | Long | UK |
MYGN Myriad Genetics, Inc. | 99.69 k | 5.22 k shares | 0.13 | Common equity | Long | USA |
IRWD Ironwood Pharmaceuticals Inc - Ordinary Shares | 98.52 k | 9.95 k shares | 0.13 | Common equity | Long | USA |
IOVA Iovance Biotherapeutics Inc | 95.91 k | 15.80 k shares | 0.13 | Common equity | Long | USA |
MIRM Mirum Pharmaceuticals Inc | 95.28 k | 2.97 k shares | 0.13 | Common equity | Long | USA |
SUPN Supernus Pharmaceuticals Inc | 94.88 k | 3.48 k shares | 0.13 | Common equity | Long | USA |
Zai Lab Ltd.
|
92.87 k | 3.40 k shares | 0.12 | Common equity | Long | Cayman Islands |
Merus NV
|
91.04 k | 3.68 k shares | 0.12 | Common equity | Long | Netherlands |
SMMT Summit Therapeutics Inc | 90.32 k | 44.50 k shares | 0.12 | Common equity | Long | USA |
RXRX Recursion Pharmaceuticals Inc - Ordinary Shares | 89.14 k | 13.01 k shares | 0.12 | Common equity | Long | USA |
TWST Twist Bioscience Corp | 88.02 k | 3.66 k shares | 0.12 | Common equity | Long | USA |
ABCL AbCellera Biologics Inc | 86.92 k | 18.46 k shares | 0.12 | Common equity | Long | Canada |
Genmab A/S
|
84.56 k | 2.68 k shares | 0.11 | Common equity | Long | Denmark |
Novocure Ltd.
|
83.42 k | 6.80 k shares | 0.11 | Common equity | Long | Jersey |
VIR Vir Biotechnology Inc | 81.25 k | 8.56 k shares | 0.11 | Common equity | Long | USA |
PCRX Pacira BioSciences Inc | 80.72 k | 2.96 k shares | 0.11 | Common equity | Long | USA |
AUPH Aurinia Pharmaceuticals Inc | 79.02 k | 9.15 k shares | 0.11 | Common equity | Long | Canada |
AGIO Agios Pharmaceuticals Inc | 78.78 k | 3.54 k shares | 0.11 | Common equity | Long | USA |
CureVac NV
|
77.10 k | 14.28 k shares | 0.10 | Common equity | Long | Netherlands |
Grifols SA
|
75.40 k | 7.78 k shares | 0.10 | Common equity | Long | Spain |
ARVN Arvinas Inc | 74.92 k | 3.41 k shares | 0.10 | Common equity | Long | USA |
SAGE Sage Therapeutics Inc | 74.78 k | 3.82 k shares | 0.10 | Common equity | Long | USA |
SNDX Syndax Pharmaceuticals Inc | 73.77 k | 4.43 k shares | 0.10 | Common equity | Long | USA |
KYMR Kymera Therapeutics Inc | 73.37 k | 3.53 k shares | 0.10 | Common equity | Long | USA |
MORF Morphic Holding Inc | 72.40 k | 3.06 k shares | 0.10 | Common equity | Long | USA |
BCRX Biocryst Pharmaceuticals Inc. | 71.06 k | 12.09 k shares | 0.10 | Common equity | Long | USA |
XNCR Xencor Inc | 70.88 k | 3.87 k shares | 0.09 | Common equity | Long | USA |
PTGX Protagonist Therapeutics Inc | 66.83 k | 3.67 k shares | 0.09 | Common equity | Long | USA |
AVDL Avadel Pharmaceuticals plc | 65.67 k | 5.69 k shares | 0.09 | Common equity | Long | Ireland |
LGND Ligand Pharmaceuticals, Inc. - Ordinary Shares | 64.55 k | 1.11 k shares | 0.09 | Common equity | Long | USA |
GERN Geron Corp. | 64.42 k | 33.38 k shares | 0.09 | Common equity | Long | USA |
ANIP ANI Pharmaceuticals Inc | 64.35 k | 1.29 k shares | 0.09 | Common equity | Long | USA |
DAWN Day One Biopharmaceuticals Inc | 64.23 k | 5.55 k shares | 0.09 | Common equity | Long | USA |
DCPH Deciphera Pharmaceuticals Inc | 63.38 k | 5.03 k shares | 0.08 | Common equity | Long | USA |
ARDX Ardelyx Inc | 62.66 k | 13.89 k shares | 0.08 | Common equity | Long | USA |
MNKD Mannkind Corp | 61.95 k | 17.11 k shares | 0.08 | Common equity | Long | USA |
RLAY Relay Therapeutics Inc | 61.60 k | 7.79 k shares | 0.08 | Common equity | Long | USA |
AMLX Amylyx Pharmaceuticals Inc | 60.85 k | 4.30 k shares | 0.08 | Common equity | Long | USA |
AKRO Akero Therapeutics Inc | 59.38 k | 3.55 k shares | 0.08 | Common equity | Long | USA |
INBX Inhibrx Inc | 57.87 k | 2.79 k shares | 0.08 | Common equity | Long | USA |
VRNA Verona Pharma Plc | 57.73 k | 4.27 k shares | 0.08 | Common equity | Long | UK |
INVA Innoviva Inc | 57.52 k | 4.15 k shares | 0.08 | Common equity | Long | USA |
KROS Keros Therapeutics Inc | 57.37 k | 1.89 k shares | 0.08 | Common equity | Long | USA |
ALPN Alpine Immune Sciences Inc | 57.21 k | 3.69 k shares | 0.08 | Common equity | Long | USA |
COLL Collegium Pharmaceutical Inc | 56.74 k | 2.21 k shares | 0.08 | Common equity | Long | USA |
SRRK Scholar Rock Holding Corp | 55.42 k | 4.40 k shares | 0.07 | Common equity | Long | USA |
Repurchase Agreement
Barclays Capital, Inc.
|
55.09 k | 55.09 k principal | 0.07 | Repurchase agreement | Long | USA |
EDIT Editas Medicine Inc | 54.82 k | 5.21 k shares | 0.07 | Common equity | Long | USA |
RGNX Regenxbio Inc | 54.70 k | 2.80 k shares | 0.07 | Common equity | Long | USA |
ADMA Adma Biologics Inc | 53.07 k | 14.34 k shares | 0.07 | Common equity | Long | USA |
PLRX Pliant Therapeutics Inc | 52.99 k | 3.82 k shares | 0.07 | Common equity | Long | USA |
SANA Sana Biotechnology Inc | 51.00 k | 12.56 k shares | 0.07 | Common equity | Long | USA |
ZNTL Zentalis Pharmaceuticals Inc | 50.67 k | 4.50 k shares | 0.07 | Common equity | Long | USA |
TNGX Tango Therapeutics Inc | 49.40 k | 6.50 k shares | 0.07 | Common equity | Long | USA |
GLPG Galapagos NV | 46.64 k | 1.25 k shares | 0.06 | Common equity | Long | Belgium |
VERV Verve Therapeutics Inc | 45.83 k | 4.06 k shares | 0.06 | Common equity | Long | USA |
KURA Kura Oncology Inc | 45.78 k | 4.73 k shares | 0.06 | Common equity | Long | USA |
DYN Dyne Therapeutics Inc | 43.12 k | 3.89 k shares | 0.06 | Common equity | Long | USA |
MRVI Maravai LifeSciences Holdings Inc - Ordinary Shares | 42.91 k | 8.41 k shares | 0.06 | Common equity | Long | USA |
REPL Replimune Group Inc | 42.06 k | 3.76 k shares | 0.06 | Common equity | Long | USA |
COGT Cogent Biosciences Inc | 41.81 k | 5.45 k shares | 0.06 | Common equity | Long | USA |
NVAX Novavax, Inc. | 41.64 k | 7.57 k shares | 0.06 | Common equity | Long | USA |
HLVX HilleVax Inc | 41.27 k | 3.01 k shares | 0.06 | Common equity | Long | USA |
Arcturus Therapeutics Holdings, Inc. | 40.60 k | 1.70 k shares | 0.05 | Common equity | Long | USA |
ADPT Adaptive Biotechnologies Corp | 40.41 k | 9.23 k shares | 0.05 | Common equity | Long | USA |
ETNB 89bio Inc | 38.70 k | 4.81 k shares | 0.05 | Common equity | Long | USA |
HCM HUTCHMED (China) Limited | 38.16 k | 1.98 k shares | 0.05 | Common equity | Long | Cayman Islands |
RVNC Revance Therapeutics Inc | 37.98 k | 5.61 k shares | 0.05 | Common equity | Long | USA |
AVXL Anavex Life Sciences Corporation | 37.69 k | 5.23 k shares | 0.05 | Common equity | Long | USA |
RNA Avidity Biosciences Inc | 36.93 k | 4.73 k shares | 0.05 | Common equity | Long | USA |
Kiniksa Pharmaceuticals Ltd., Class A
|
36.33 k | 2.25 k shares | 0.05 | Common equity | Long | Bermuda |
Theravance Biopharma, Inc.
|
35.30 k | 3.37 k shares | 0.05 | Common equity | Long | Cayman Islands |
EOLS Evolus Inc | 34.40 k | 3.63 k shares | 0.05 | Common equity | Long | USA |
TARS Tarsus Pharmaceuticals Inc | 34.28 k | 2.07 k shares | 0.05 | Common equity | Long | USA |
BMEA Biomea Fusion Inc | 34.24 k | 2.27 k shares | 0.05 | Common equity | Long | USA |
CSTL Castle Biosciences Inc | 34.18 k | 1.71 k shares | 0.05 | Common equity | Long | USA |
FDMT 4D Molecular Therapeutics Inc | 34.12 k | 2.68 k shares | 0.05 | Common equity | Long | USA |
WaVe Life Sciences Ltd.
|
33.53 k | 6.31 k shares | 0.04 | Common equity | Long | Singapore |
CRBU Caribou Biosciences Inc | 33.05 k | 5.63 k shares | 0.04 | Common equity | Long | USA |
MGNX Macrogenics Inc | 32.45 k | 3.95 k shares | 0.04 | Common equity | Long | USA |
PETQ PetIQ Inc - Ordinary Shares | 32.42 k | 1.86 k shares | 0.04 | Common equity | Long | USA |
RAPT RAPT Therapeutics Inc | 31.83 k | 2.19 k shares | 0.04 | Common equity | Long | USA |
MXCT MaxCyte Inc | 31.35 k | 6.60 k shares | 0.04 | Common equity | Long | USA |
TVTX Travere Therapeutics Inc | 30.04 k | 4.78 k shares | 0.04 | Common equity | Long | USA |
SPRY ARS Pharmaceuticals Inc | 29.44 k | 6.10 k shares | 0.04 | Common equity | Long | USA |
ALEC Alector Inc | 28.98 k | 5.35 k shares | 0.04 | Common equity | Long | USA |
LYEL Lyell Immunopharma Inc | 27.70 k | 16.01 k shares | 0.04 | Common equity | Long | USA |
BLUE Bluebird bio Inc | 25.97 k | 6.80 k shares | 0.03 | Common equity | Long | USA |
UroGen Pharma Ltd.
|
25.48 k | 1.93 k shares | 0.03 | Common equity | Long | Israel |
PHAT Phathom Pharmaceuticals Inc | 25.32 k | 3.62 k shares | 0.03 | Common equity | Long | USA |
ALLO Allogene Therapeutics Inc | 25.12 k | 10.69 k shares | 0.03 | Common equity | Long | USA |
SIGA SIGA Technologies Inc | 24.62 k | 4.53 k shares | 0.03 | Common equity | Long | USA |
EWTX Edgewise Therapeutics Inc | 24.61 k | 4.05 k shares | 0.03 | Common equity | Long | USA |
ALXO Alx Oncology Holdings Inc | 24.26 k | 3.09 k shares | 0.03 | Common equity | Long | USA |
BCYC Bicycle Therapeutics Plc | 24.25 k | 1.68 k shares | 0.03 | Common equity | Long | UK |
ANAB AnaptysBio Inc | 23.92 k | 1.69 k shares | 0.03 | Common equity | Long | USA |
CGEM Cullinan Therapeutics Inc | 22.33 k | 2.73 k shares | 0.03 | Common equity | Long | USA |
NAUT Nautilus Biotechnology Inc | 21.91 k | 7.97 k shares | 0.03 | Common equity | Long | USA |
ABUS Arbutus Biopharma Corp | 21.91 k | 10.69 k shares | 0.03 | Common equity | Long | Canada |
MRNS Marinus Pharmaceuticals Inc | 21.72 k | 3.23 k shares | 0.03 | Common equity | Long | USA |
ITOS ITeos Therapeutics Inc | 21.37 k | 2.28 k shares | 0.03 | Common equity | Long | USA |
GRCL Gracell Biotechnologies Inc | 21.16 k | 4.34 k shares | 0.03 | Common equity | Long | Cayman Islands |
HROW Harrow Inc | 20.68 k | 2.24 k shares | 0.03 | Common equity | Long | USA |
uniQure NV
|
20.64 k | 3.04 k shares | 0.03 | Common equity | Long | Netherlands |
CNTA Centessa Pharmaceuticals plc | 20.20 k | 3.37 k shares | 0.03 | Common equity | Long | UK |
MeiraGTx Holdings plc
|
19.83 k | 3.80 k shares | 0.03 | Common equity | Long | Cayman Islands |
AMRN Amarin Corp | 19.19 k | 24.55 k shares | 0.03 | Common equity | Long | UK |
NRIX Nurix Therapeutics Inc | 19.12 k | 3.07 k shares | 0.03 | Common equity | Long | USA |
FULC Fulcrum Therapeutics Inc | 18.93 k | 3.94 k shares | 0.03 | Common equity | Long | USA |
PGEN Precigen Inc | 18.25 k | 16.29 k shares | 0.02 | Common equity | Long | USA |
HUMA Humacyte Inc | 17.48 k | 6.60 k shares | 0.02 | Common equity | Long | USA |
EXAI Exscientia Plc | 17.36 k | 2.85 k shares | 0.02 | Common equity | Long | UK |
TERN Terns Pharmaceuticals Inc | 17.33 k | 3.90 k shares | 0.02 | Common equity | Long | USA |
ME 23andMe Holding Co - Ordinary Shares | 16.73 k | 19.45 k shares | 0.02 | Common equity | Long | USA |
LXRX Lexicon Pharmaceuticals Inc | 16.56 k | 15.62 k shares | 0.02 | Common equity | Long | USA |
XERS Xeris Pharmaceuticals Inc | 16.38 k | 8.81 k shares | 0.02 | Common equity | Long | USA |
ERAS Erasca Inc | 16.38 k | 9.63 k shares | 0.02 | Common equity | Long | USA |
PSTX Poseida Therapeutics Inc | 16.27 k | 6.09 k shares | 0.02 | Common equity | Long | USA |
AVIR Atea Pharmaceuticals Inc | 15.90 k | 5.32 k shares | 0.02 | Common equity | Long | USA |
FATE Fate Therapeutics Inc | 15.65 k | 6.29 k shares | 0.02 | Common equity | Long | USA |
CHRS Coherus Biosciences Inc | 15.12 k | 7.10 k shares | 0.02 | Common equity | Long | USA |
IGMS IGM Biosciences Inc | 14.12 k | 2.10 k shares | 0.02 | Common equity | Long | USA |